Probe Scientific Ltd and University College London

Medical device company, Probe Scientific, is developing its existing microdialysis technology to provide therapeutic antibiotic drug monitoring for healthcare practitioners at the bedside. They will work with UCL’s Professor Mervyn Singer, Head of the Centre for Intensive Care, and his group of leading experts in sepsis, infection, and blood monitoring; to validate the technology for future use in a clinical setting.